First-Trimester Placental Growth Factor in Screening for Gestational Diabetes

作者：Mosimann Beatrice; Amylidi Sophia; Risch Lorenz; Wiedemann Ute; Surbek Daniel; Baumann Marc; Stettler Christoph; Raio Luigi

来源：Fetal Diagnosis and Therapy, 2016, 39(4): 287-291.

DOI：10.1159/000441027

• Placental growth factor
• First trimester
• Maternal serum screening
• Gestational diabetes
• Glycosylated hemoglobin

Objective: The aim of this study was first to assess whether first-trimester serum concentrations of placental growth factor (PlGF) differ between patients with and without gestational diabetes (GDM) and second to test whether there is a correlation between glycosylated hemoglobin (HbA1c), a factor recently shown to be useful in predicting GDM, and PlGF. Methods: PlGF was measured at 8-14 weeks with the Kryptor Immunoassay Analyzer (Brahms, Berlin, Germany). Absolute values were converted to multiples of the median using the software provided by the Fetal Medicine Foundation London. GDM was diagnosed using internationally accepted criteria. HbA1c levels were quantified using the TOSOH G7 automated hemoglobin analyzer. Results: From January to December 2014, 328 women were included in the study, 51 (15.5%) of whom developed GDM. First-trimester PlGF quantification does not discriminate between women at risk to develop GDM and controls, while HbA1c is able to do so. No correlation was found between PlGF and HbA1c. Conclusion: Our findings do not lend support to the hypothesis that early PlGF values are different in women who later develop GDM.

• 出版日期2016